At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MBOT Microbot Medical Inc
Market Closed 07-05 16:00:00 EDT
1.07
+0.02
+1.43%
盘后1.07
+0.00+0.29%
18:08 EDT
High1.07
Low1.03
Vol67.33K
Open1.03
D1 Closing1.05
Amplitude3.81%
Mkt Cap17.00M
Tradable Cap16.71M
Total Shares15.97M
T/O70.35K
T/O Rate0.43%
Tradable Shares15.69M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Microbot Medical (MBOT) Inks Agreement to Begin LIBERTY Trial
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, a disposable robotic system for use in endovascular interventional procedures, such as cardiovascular, peripheral, and neurovascular; NovaCross, an intraluminal revascularization device; ViRob, an autonomous crawling micro-robot that cam crawl in various natural spaces within the human body, including blood vessels, the digestive tract and the respiratory system, as well as artificial spaces such as shunts, catheters, ports, etc.; TipCAT, a disposable self-propelled locomotive device for tubular anatomies; and One & Done platform. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.